

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 5.82582317 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 5.70731108 |
| 3 | intestinal absorption (GO:0050892) | 5.57680206 |
| 4 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.42621224 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 5.28118171 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 5.05710655 |
| 7 | fructose metabolic process (GO:0006000) | 5.04312653 |
| 8 | angiotensin maturation (GO:0002003) | 4.64468926 |
| 9 | regulation of cholesterol homeostasis (GO:2000188) | 4.53498462 |
| 10 | regulation of cellular extravasation (GO:0002691) | 4.41428681 |
| 11 | regulation of sequestering of triglyceride (GO:0010889) | 4.37822297 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 4.36470783 |
| 13 | hormone catabolic process (GO:0042447) | 4.29411681 |
| 14 | positive regulation of p38MAPK cascade (GO:1900745) | 4.19749341 |
| 15 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.18080746 |
| 16 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.16928223 |
| 17 | endocrine process (GO:0050886) | 4.16928223 |
| 18 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.16928223 |
| 19 | peptide catabolic process (GO:0043171) | 4.14295271 |
| 20 | urea cycle (GO:0000050) | 4.11606610 |
| 21 | tolerance induction (GO:0002507) | 4.10598950 |
| 22 | regulation of bile acid biosynthetic process (GO:0070857) | 4.05994525 |
| 23 | regulation of cholesterol storage (GO:0010885) | 4.03286167 |
| 24 | positive regulation of heat generation (GO:0031652) | 3.94631012 |
| 25 | urea metabolic process (GO:0019627) | 3.93105171 |
| 26 | virion attachment to host cell (GO:0019062) | 3.90319667 |
| 27 | adhesion of symbiont to host cell (GO:0044650) | 3.90319667 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88707385 |
| 29 | valine metabolic process (GO:0006573) | 3.87545441 |
| 30 | triglyceride catabolic process (GO:0019433) | 3.86469767 |
| 31 | regulation of systemic arterial blood pressure (GO:0003073) | 3.83553233 |
| 32 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.82767610 |
| 33 | brown fat cell differentiation (GO:0050873) | 3.82606750 |
| 34 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.79236891 |
| 35 | regulation of memory T cell differentiation (GO:0043380) | 3.71659868 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.70765793 |
| 37 | embryonic process involved in female pregnancy (GO:0060136) | 3.69330858 |
| 38 | positive regulation of lipid catabolic process (GO:0050996) | 3.65347302 |
| 39 | drug metabolic process (GO:0017144) | 3.64429728 |
| 40 | white fat cell differentiation (GO:0050872) | 3.63599913 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 3.63161663 |
| 42 | positive regulation of lipid storage (GO:0010884) | 3.63080329 |
| 43 | positive regulation of fatty acid oxidation (GO:0046321) | 3.63049225 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 3.60247851 |
| 45 | * diacylglycerol metabolic process (GO:0046339) | 3.59529512 |
| 46 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.57626674 |
| 47 | adhesion of symbiont to host (GO:0044406) | 3.56497761 |
| 48 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.56238679 |
| 49 | regulation of cGMP biosynthetic process (GO:0030826) | 3.53882400 |
| 50 | glycolipid catabolic process (GO:0019377) | 3.52451775 |
| 51 | regulation of activation of Janus kinase activity (GO:0010533) | 3.50580846 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 3.49978708 |
| 53 | antimicrobial humoral response (GO:0019730) | 3.49536380 |
| 54 | antibacterial humoral response (GO:0019731) | 3.45600117 |
| 55 | interferon-gamma production (GO:0032609) | 3.42982173 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.42339296 |
| 57 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.42339296 |
| 58 | * triglyceride biosynthetic process (GO:0019432) | 3.42141769 |
| 59 | regulation of p38MAPK cascade (GO:1900744) | 3.41744882 |
| 60 | acylglycerol catabolic process (GO:0046464) | 3.41059199 |
| 61 | neutral lipid catabolic process (GO:0046461) | 3.41059199 |
| 62 | peptide hormone processing (GO:0016486) | 3.40706709 |
| 63 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.39017809 |
| 64 | positive regulation of pseudopodium assembly (GO:0031274) | 3.37296938 |
| 65 | acylglycerol homeostasis (GO:0055090) | 3.36693755 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.36693755 |
| 67 | biotin metabolic process (GO:0006768) | 3.35792175 |
| 68 | regulation of vitamin metabolic process (GO:0030656) | 3.34493787 |
| 69 | * lipid storage (GO:0019915) | 3.34469908 |
| 70 | NADH metabolic process (GO:0006734) | 3.32538689 |
| 71 | T-helper cell differentiation (GO:0042093) | 3.30721230 |
| 72 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.30721230 |
| 73 | renal system process involved in regulation of blood volume (GO:0001977) | 3.30287792 |
| 74 | GDP-mannose metabolic process (GO:0019673) | 3.29433664 |
| 75 | mature B cell differentiation involved in immune response (GO:0002313) | 3.29410773 |
| 76 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.28694209 |
| 77 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.24047212 |
| 78 | regulation of triglyceride metabolic process (GO:0090207) | 3.21806784 |
| 79 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.21711209 |
| 80 | * neutral lipid biosynthetic process (GO:0046460) | 3.20763704 |
| 81 | * acylglycerol biosynthetic process (GO:0046463) | 3.20763704 |
| 82 | pentose-phosphate shunt (GO:0006098) | 3.19991687 |
| 83 | regulation of fever generation (GO:0031620) | 3.18502151 |
| 84 | bile acid and bile salt transport (GO:0015721) | 3.15464495 |
| 85 | lipoprotein metabolic process (GO:0042157) | 3.15405615 |
| 86 | regulation of sterol transport (GO:0032371) | 3.12670611 |
| 87 | regulation of cholesterol transport (GO:0032374) | 3.12670611 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 3.12498634 |
| 89 | alkaloid metabolic process (GO:0009820) | 3.09625030 |
| 90 | fatty acid beta-oxidation (GO:0006635) | 3.06052643 |
| 91 | NADPH regeneration (GO:0006740) | 3.04577448 |
| 92 | regulation of podosome assembly (GO:0071801) | 3.04433945 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.02068110 |
| 94 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.01690365 |
| 95 | flavonoid metabolic process (GO:0009812) | 3.01175419 |
| 96 | regulation of pseudopodium assembly (GO:0031272) | 3.00695875 |
| 97 | vitamin A metabolic process (GO:0006776) | 3.00664223 |
| 98 | negative regulation of lipid storage (GO:0010888) | 3.00170204 |
| 99 | negative regulation of protein autophosphorylation (GO:0031953) | 2.98054015 |
| 100 | cGMP-mediated signaling (GO:0019934) | 2.96197740 |
| 101 | fatty acid transmembrane transport (GO:1902001) | 2.95414479 |
| 102 | plasma lipoprotein particle remodeling (GO:0034369) | 2.95279640 |
| 103 | protein-lipid complex remodeling (GO:0034368) | 2.95279640 |
| 104 | macromolecular complex remodeling (GO:0034367) | 2.95279640 |
| 105 | phospholipid efflux (GO:0033700) | 2.93590846 |
| 106 | vitamin transport (GO:0051180) | 2.93266304 |
| 107 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.93176965 |
| 108 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.92574120 |
| 109 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.89907716 |
| 110 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.89803330 |
| 111 | leukotriene metabolic process (GO:0006691) | 2.89786909 |
| 112 | regulation of heat generation (GO:0031650) | 2.89723408 |
| 113 | regulation of cholesterol metabolic process (GO:0090181) | 2.89202491 |
| 114 | oligosaccharide catabolic process (GO:0009313) | 2.87847530 |
| 115 | plasma lipoprotein particle clearance (GO:0034381) | 2.86901464 |
| 116 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86330268 |
| 117 | regulation of fatty acid oxidation (GO:0046320) | 2.85600501 |
| 118 | regulation of lipid storage (GO:0010883) | 2.85586244 |
| 119 | * protein-lipid complex assembly (GO:0065005) | 2.85246310 |
| 120 | high-density lipoprotein particle remodeling (GO:0034375) | 2.85203737 |
| 121 | defense response to fungus (GO:0050832) | 2.84457532 |
| 122 | transcytosis (GO:0045056) | 2.84423948 |
| 123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.84343625 |
| 124 | vitamin transmembrane transport (GO:0035461) | 2.83536386 |
| 125 | carnitine shuttle (GO:0006853) | 2.82837561 |
| 126 | positive regulation of respiratory burst (GO:0060267) | 2.82703385 |
| 127 | ethanol oxidation (GO:0006069) | 2.81691140 |
| 128 | ceramide catabolic process (GO:0046514) | 2.81655643 |
| 129 | lipoprotein transport (GO:0042953) | 2.81242327 |
| 130 | growth hormone receptor signaling pathway (GO:0060396) | 2.80118990 |
| 131 | T cell differentiation involved in immune response (GO:0002292) | 2.80090800 |
| 132 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.80090800 |
| 133 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.80090800 |
| 134 | cellular response to zinc ion (GO:0071294) | 2.80032170 |
| 135 | regulation of cGMP metabolic process (GO:0030823) | 2.79465350 |
| 136 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.78789368 |
| 137 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78751912 |
| 138 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78751912 |
| 139 | regulation of extracellular matrix disassembly (GO:0010715) | 2.78314537 |
| 140 | arginine metabolic process (GO:0006525) | 2.78186609 |
| 141 | glucose 6-phosphate metabolic process (GO:0051156) | 2.77813196 |
| 142 | mannose metabolic process (GO:0006013) | 2.77639995 |
| 143 | digestion (GO:0007586) | 2.77015429 |
| 144 | leukocyte aggregation (GO:0070486) | 2.76437769 |
| 145 | NIK/NF-kappaB signaling (GO:0038061) | 2.73979032 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73639740 |
| 147 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.73482651 |
| 148 | Peyers patch development (GO:0048541) | 2.73482651 |
| 149 | * plasma lipoprotein particle assembly (GO:0034377) | 2.73445325 |
| 150 | positive regulation of histone deacetylation (GO:0031065) | 2.73276831 |
| 151 | carnitine transmembrane transport (GO:1902603) | 2.71986724 |
| 152 | detection of bacterium (GO:0016045) | 2.71799642 |
| 153 | fatty acid catabolic process (GO:0009062) | 2.71763998 |
| 154 | proline biosynthetic process (GO:0006561) | 2.70362289 |
| 155 | sphingolipid catabolic process (GO:0030149) | 2.69903336 |
| 156 | * triglyceride metabolic process (GO:0006641) | 2.69822336 |
| 157 | response to interleukin-15 (GO:0070672) | 2.69793047 |
| 158 | sexual reproduction (GO:0019953) | 2.68466807 |
| 159 | negative regulation of cell killing (GO:0031342) | 2.68310403 |
| 160 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68310403 |
| 161 | regulation of response to interferon-gamma (GO:0060330) | 2.68211514 |
| 162 | cellular response to reactive nitrogen species (GO:1902170) | 2.67968184 |
| 163 | fatty acid oxidation (GO:0019395) | 2.67102983 |
| 164 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.66822391 |
| 165 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.66628823 |
| 166 | cellular response to interleukin-15 (GO:0071350) | 2.66562128 |
| 167 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.65347894 |
| 168 | homocysteine metabolic process (GO:0050667) | 2.64741098 |
| 169 | carnitine transport (GO:0015879) | 2.64709906 |
| 170 | amino-acid betaine transport (GO:0015838) | 2.64709906 |
| 171 | cellular response to nitric oxide (GO:0071732) | 2.64594310 |
| 172 | oxaloacetate metabolic process (GO:0006107) | 2.64367878 |
| 173 | cellular response to lithium ion (GO:0071285) | 2.63549517 |
| 174 | regulation of respiratory burst (GO:0060263) | 2.62595455 |
| 175 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62207269 |
| 176 | glycerol metabolic process (GO:0006071) | 2.61019805 |
| 177 | drug transport (GO:0015893) | 2.60194985 |
| 178 | fat-soluble vitamin metabolic process (GO:0006775) | 2.58061903 |
| 179 | detection of other organism (GO:0098543) | 2.57078892 |
| 180 | proline metabolic process (GO:0006560) | 2.56729688 |
| 181 | arachidonic acid metabolic process (GO:0019369) | 2.56635026 |
| 182 | vitamin biosynthetic process (GO:0009110) | 2.56536968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.15864475 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.16336434 |
| 3 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.30768491 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.28526835 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21567828 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.06698640 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98225626 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.94783589 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.70092782 |
| 10 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.66728939 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59777571 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44781541 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36824387 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16439725 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06517145 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04479450 |
| 17 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.98999102 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.96260637 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90013848 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86659392 |
| 21 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86537448 |
| 22 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.85829966 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 1.81888054 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.80311123 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.80047177 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.78347977 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76233611 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.74029391 |
| 29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73770032 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73242288 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69576888 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.68969479 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68822892 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.66934039 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66826715 |
| 36 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.62890479 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61763108 |
| 38 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.60821788 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60275850 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59982191 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59329445 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.59194748 |
| 43 | SA1_27219007_Chip-Seq_Bcells_Human | 1.56352429 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56228427 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55709358 |
| 46 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55412384 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54564375 |
| 48 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.52381690 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52045900 |
| 50 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51187665 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50360349 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50066532 |
| 53 | * MYB_26560356_Chip-Seq_TH1_Human | 1.49474785 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48371795 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47970351 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46585240 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46033737 |
| 58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43575063 |
| 59 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.43355323 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43114331 |
| 61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41955158 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41845097 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40260337 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40195743 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39795073 |
| 66 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38788136 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37544672 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37535935 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37481769 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35833144 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35052796 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34094359 |
| 73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33066407 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32145519 |
| 75 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31986631 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31633002 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31333839 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30964510 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30052974 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29536092 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.29090266 |
| 82 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.28914515 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28771771 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.27650731 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27611216 |
| 86 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.27068903 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25073163 |
| 88 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24450222 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23017176 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22749454 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22718850 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22198667 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20289304 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19694284 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19267831 |
| 96 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18306997 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17746650 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16905444 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.16794346 |
| 100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15839511 |
| 101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15146578 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13885130 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13692471 |
| 104 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.13351967 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13349713 |
| 106 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12990024 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12584331 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11712796 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10534886 |
| 110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10225551 |
| 111 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.09569516 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09429208 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09290833 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08922061 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08903217 |
| 116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08851197 |
| 117 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.08796327 |
| 118 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08145859 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07492477 |
| 120 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07126081 |
| 121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06967678 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06829741 |
| 123 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04406188 |
| 124 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02677386 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02168107 |
| 126 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01829882 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01823671 |
| 128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00387791 |
| 129 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.00300462 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00238030 |
| 131 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00015238 |
| 132 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99915614 |
| 133 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99515625 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99388803 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98083627 |
| 136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95768028 |
| 137 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95068859 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93576497 |
| 139 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92136094 |
| 140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90886726 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90564758 |
| 142 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89770395 |
| 143 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89591975 |
| 144 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88515400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.91636285 |
| 2 | MP0005670_abnormal_white_adipose | 3.64851144 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.55918650 |
| 4 | MP0010329_abnormal_lipoprotein_level | 2.90944352 |
| 5 | MP0001666_abnormal_nutrient_absorption | 2.62002907 |
| 6 | MP0005666_abnormal_adipose_tissue | 2.58001223 |
| 7 | MP0003724_increased_susceptibility_to | 2.56935418 |
| 8 | MP0005409_darkened_coat_color | 2.56306835 |
| 9 | MP0009840_abnormal_foam_cell | 2.48565064 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 2.38827988 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.16478072 |
| 12 | MP0000685_abnormal_immune_system | 2.14823198 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.13729758 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.12745502 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.12489290 |
| 16 | MP0005451_abnormal_body_composition | 2.06919255 |
| 17 | MP0009785_altered_susceptibility_to | 2.06127323 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.04745203 |
| 19 | MP0005365_abnormal_bile_salt | 2.02219889 |
| 20 | MP0003436_decreased_susceptibility_to | 2.00855073 |
| 21 | MP0004130_abnormal_muscle_cell | 1.98497008 |
| 22 | MP0009278_abnormal_bone_marrow | 1.98262892 |
| 23 | MP0001873_stomach_inflammation | 1.95942193 |
| 24 | MP0003866_abnormal_defecation | 1.94456331 |
| 25 | MP0002971_abnormal_brown_adipose | 1.93253511 |
| 26 | MP0000678_abnormal_parathyroid_gland | 1.83078483 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.82308872 |
| 28 | MP0004858_abnormal_nervous_system | 1.81552216 |
| 29 | MP0009115_abnormal_fat_cell | 1.81308983 |
| 30 | MP0004147_increased_porphyrin_level | 1.79026925 |
| 31 | * MP0000609_abnormal_liver_physiology | 1.77796150 |
| 32 | MP0005375_adipose_tissue_phenotype | 1.74506699 |
| 33 | MP0003879_abnormal_hair_cell | 1.71403575 |
| 34 | MP0005332_abnormal_amino_acid | 1.69258223 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.68570067 |
| 36 | MP0002405_respiratory_system_inflammati | 1.68203520 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.65216893 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.65216893 |
| 39 | MP0001790_abnormal_immune_system | 1.61261900 |
| 40 | MP0005387_immune_system_phenotype | 1.61261900 |
| 41 | MP0005166_decreased_susceptibility_to | 1.59481202 |
| 42 | MP0003252_abnormal_bile_duct | 1.57045067 |
| 43 | * MP0002118_abnormal_lipid_homeostasis | 1.54750149 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.54606683 |
| 45 | MP0005334_abnormal_fat_pad | 1.54550986 |
| 46 | MP0004947_skin_inflammation | 1.53628193 |
| 47 | MP0000490_abnormal_crypts_of | 1.52066908 |
| 48 | MP0001800_abnormal_humoral_immune | 1.50157425 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.44259854 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.41629724 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.41077645 |
| 52 | MP0005085_abnormal_gallbladder_physiolo | 1.41052724 |
| 53 | MP0002419_abnormal_innate_immunity | 1.41006302 |
| 54 | MP0001188_hyperpigmentation | 1.40609179 |
| 55 | MP0005671_abnormal_response_to | 1.40541305 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.35626174 |
| 57 | MP0001765_abnormal_ion_homeostasis | 1.34650056 |
| 58 | MP0005025_abnormal_response_to | 1.33939136 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.33714422 |
| 60 | * MP0001664_abnormal_digestion | 1.33687283 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.33423742 |
| 62 | MP0002723_abnormal_immune_serum | 1.33333768 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.30617325 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.30197098 |
| 65 | MP0008961_abnormal_basal_metabolism | 1.29714493 |
| 66 | MP0008260_abnormal_autophagy | 1.29313860 |
| 67 | MP0002452_abnormal_antigen_presenting | 1.28943659 |
| 68 | MP0001819_abnormal_immune_cell | 1.28857499 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.28227478 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.28183090 |
| 71 | MP0001853_heart_inflammation | 1.27832537 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.27208916 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.25849532 |
| 74 | MP0000538_abnormal_urinary_bladder | 1.25105775 |
| 75 | * MP0005448_abnormal_energy_balance | 1.24318649 |
| 76 | MP0000343_altered_response_to | 1.22848612 |
| 77 | MP0000858_altered_metastatic_potential | 1.22125510 |
| 78 | MP0001835_abnormal_antigen_presentation | 1.20718323 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19025226 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.16791122 |
| 81 | MP0002060_abnormal_skin_morphology | 1.15710888 |
| 82 | MP0002970_abnormal_white_adipose | 1.15697630 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.15493665 |
| 84 | MP0003868_abnormal_feces_composition | 1.14351888 |
| 85 | MP0002136_abnormal_kidney_physiology | 1.13816875 |
| 86 | MP0003828_pulmonary_edema | 1.12204900 |
| 87 | MP0000477_abnormal_intestine_morphology | 1.09893636 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.09023733 |
| 89 | MP0002254_reproductive_system_inflammat | 1.08322071 |
| 90 | MP0003303_peritoneal_inflammation | 1.07996793 |
| 91 | MP0005381_digestive/alimentary_phenotyp | 1.06346106 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.05969547 |
| 93 | MP0006082_CNS_inflammation | 1.05645352 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.05156833 |
| 95 | MP0002933_joint_inflammation | 1.03702694 |
| 96 | MP0000003_abnormal_adipose_tissue | 1.01523175 |
| 97 | MP0000604_amyloidosis | 1.01140414 |
| 98 | MP0001849_ear_inflammation | 0.99690112 |
| 99 | MP0001663_abnormal_digestive_system | 0.99517587 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.99212581 |
| 101 | MP0003448_altered_tumor_morphology | 0.98764756 |
| 102 | * MP0001881_abnormal_mammary_gland | 0.98039658 |
| 103 | MP0000716_abnormal_immune_system | 0.97343354 |
| 104 | MP0001764_abnormal_homeostasis | 0.96802735 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.96677737 |
| 106 | MP0001756_abnormal_urination | 0.96417072 |
| 107 | MP0008469_abnormal_protein_level | 0.96201237 |
| 108 | MP0005464_abnormal_platelet_physiology | 0.95459340 |
| 109 | MP0002006_tumorigenesis | 0.95020418 |
| 110 | MP0003329_amyloid_beta_deposits | 0.94922877 |
| 111 | MP0002398_abnormal_bone_marrow | 0.94409047 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90959459 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.90811928 |
| 114 | MP0000249_abnormal_blood_vessel | 0.89852018 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.89437891 |
| 116 | MP0002796_impaired_skin_barrier | 0.88883326 |
| 117 | MP0003045_fibrosis | 0.88868992 |
| 118 | MP0002148_abnormal_hypersensitivity_rea | 0.87196281 |
| 119 | * MP0004019_abnormal_vitamin_homeostasis | 0.86660185 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.85765953 |
| 121 | MP0002722_abnormal_immune_system | 0.85162436 |
| 122 | MP0000689_abnormal_spleen_morphology | 0.83691298 |
| 123 | MP0005535_abnormal_body_temperature | 0.83125559 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.82863818 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.82314792 |
| 126 | MP0003075_altered_response_to | 0.82202350 |
| 127 | MP0002429_abnormal_blood_cell | 0.81892532 |
| 128 | MP0001986_abnormal_taste_sensitivity | 0.81477755 |
| 129 | MP0009763_increased_sensitivity_to | 0.79973436 |
| 130 | MP0004510_myositis | 0.79025880 |
| 131 | MP0008004_abnormal_stomach_pH | 0.78985968 |
| 132 | MP0009764_decreased_sensitivity_to | 0.77112349 |
| 133 | MP0000015_abnormal_ear_pigmentation | 0.76425566 |
| 134 | MP0004043_abnormal_pH_regulation | 0.74991163 |
| 135 | * MP0009642_abnormal_blood_homeostasis | 0.74715348 |
| 136 | MP0002822_catalepsy | 0.72712820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 5.75385521 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.53178498 |
| 3 | Optic neuritis (HP:0100653) | 5.53178498 |
| 4 | Myositis (HP:0100614) | 5.43613311 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.85364540 |
| 6 | Hydroxyprolinuria (HP:0003080) | 4.67668683 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 4.67668683 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.32775779 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 4.27997274 |
| 10 | Increased density of long bones (HP:0006392) | 4.26426399 |
| 11 | Thin bony cortex (HP:0002753) | 4.09988184 |
| 12 | Widely patent fontanelles and sutures (HP:0004492) | 4.03395466 |
| 13 | Hyperglycinuria (HP:0003108) | 3.91381531 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.86957462 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.80332486 |
| 16 | Hypertriglyceridemia (HP:0002155) | 3.61475951 |
| 17 | Hemorrhage of the eye (HP:0011885) | 3.58607045 |
| 18 | Confusion (HP:0001289) | 3.52336025 |
| 19 | Ileus (HP:0002595) | 3.39030234 |
| 20 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.34555587 |
| 21 | Pancreatitis (HP:0001733) | 3.27220408 |
| 22 | Oligomenorrhea (HP:0000876) | 3.24943478 |
| 23 | Pigmentary retinal degeneration (HP:0001146) | 3.20206225 |
| 24 | Persistence of primary teeth (HP:0006335) | 3.19011376 |
| 25 | Fat malabsorption (HP:0002630) | 3.14450298 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.10374718 |
| 27 | B lymphocytopenia (HP:0010976) | 3.09595983 |
| 28 | Abnormality of B cell number (HP:0010975) | 3.09595983 |
| 29 | Abnormality of vitamin B metabolism (HP:0004340) | 3.07699165 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07406380 |
| 31 | Pustule (HP:0200039) | 3.06875864 |
| 32 | IgM deficiency (HP:0002850) | 3.03171120 |
| 33 | Eczematoid dermatitis (HP:0000976) | 3.01547132 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 3.00594493 |
| 35 | Increased IgE level (HP:0003212) | 2.99550127 |
| 36 | Hypophosphatemia (HP:0002148) | 2.99504573 |
| 37 | Decreased circulating renin level (HP:0003351) | 2.96792918 |
| 38 | Growth hormone excess (HP:0000845) | 2.94171576 |
| 39 | Wide cranial sutures (HP:0010537) | 2.92337484 |
| 40 | Combined immunodeficiency (HP:0005387) | 2.90772112 |
| 41 | Acanthosis nigricans (HP:0000956) | 2.88756706 |
| 42 | Arterial thrombosis (HP:0004420) | 2.81720648 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.81139271 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.81139271 |
| 45 | Abnormality of complement system (HP:0005339) | 2.79756366 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.76289481 |
| 47 | Complement deficiency (HP:0004431) | 2.70496498 |
| 48 | Acanthocytosis (HP:0001927) | 2.69849720 |
| 49 | Polycythemia (HP:0001901) | 2.68880091 |
| 50 | Cupped ribs (HP:0000887) | 2.66498516 |
| 51 | Abdominal distention (HP:0003270) | 2.65772015 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.61436098 |
| 53 | Abnormality of vitamin metabolism (HP:0100508) | 2.61128655 |
| 54 | Glomerulonephritis (HP:0000099) | 2.60470801 |
| 55 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.60357663 |
| 56 | Myocardial infarction (HP:0001658) | 2.57608698 |
| 57 | Thyroiditis (HP:0100646) | 2.56920025 |
| 58 | IgA deficiency (HP:0002720) | 2.56325548 |
| 59 | Anorexia (HP:0002039) | 2.55799016 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.55593813 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.53841780 |
| 62 | Delayed epiphyseal ossification (HP:0002663) | 2.52809020 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.52803659 |
| 64 | Glycosuria (HP:0003076) | 2.48622556 |
| 65 | Abnormality of urine glucose concentration (HP:0011016) | 2.48622556 |
| 66 | Xanthomatosis (HP:0000991) | 2.48155454 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.47835831 |
| 68 | Encephalitis (HP:0002383) | 2.45730312 |
| 69 | Hemoptysis (HP:0002105) | 2.44959068 |
| 70 | Nephrolithiasis (HP:0000787) | 2.43939046 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.43495813 |
| 72 | Abnormal platelet volume (HP:0011876) | 2.42216226 |
| 73 | Nausea (HP:0002018) | 2.41973436 |
| 74 | Myoglobinuria (HP:0002913) | 2.40679249 |
| 75 | Alopecia of scalp (HP:0002293) | 2.38577072 |
| 76 | Chronic diarrhea (HP:0002028) | 2.38290171 |
| 77 | Nasal polyposis (HP:0100582) | 2.37548103 |
| 78 | Increased mean platelet volume (HP:0011877) | 2.37064507 |
| 79 | Amyloidosis (HP:0011034) | 2.36968985 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.36077228 |
| 81 | Alkalosis (HP:0001948) | 2.35851137 |
| 82 | Abnormality of the costochondral junction (HP:0000919) | 2.35622121 |
| 83 | Congenital sensorineural hearing impairment (HP:0008527) | 2.35253374 |
| 84 | Hyperammonemia (HP:0001987) | 2.33316410 |
| 85 | Myopathic facies (HP:0002058) | 2.32637119 |
| 86 | Villous atrophy (HP:0011473) | 2.31501019 |
| 87 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.31501019 |
| 88 | Malnutrition (HP:0004395) | 2.29859845 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.28215721 |
| 90 | Facial shape deformation (HP:0011334) | 2.27314843 |
| 91 | Potter facies (HP:0002009) | 2.27314843 |
| 92 | Insulin resistance (HP:0000855) | 2.24552391 |
| 93 | Hypercholesterolemia (HP:0003124) | 2.23723787 |
| 94 | Enlarged epiphyses (HP:0010580) | 2.22446060 |
| 95 | Vasculitis (HP:0002633) | 2.22350197 |
| 96 | Hyperuricemia (HP:0002149) | 2.21188185 |
| 97 | Increased purine levels (HP:0004368) | 2.21188185 |
| 98 | Bone cyst (HP:0012062) | 2.19021092 |
| 99 | Gastrointestinal infarctions (HP:0005244) | 2.18635611 |
| 100 | Epidermoid cyst (HP:0200040) | 2.18446412 |
| 101 | Rhabdomyolysis (HP:0003201) | 2.18166214 |
| 102 | Polygenic inheritance (HP:0010982) | 2.16825794 |
| 103 | Metabolic alkalosis (HP:0200114) | 2.16355277 |
| 104 | Petechiae (HP:0000967) | 2.15434400 |
| 105 | Pulmonary embolism (HP:0002204) | 2.14985701 |
| 106 | Abnormal urine phosphate concentration (HP:0012599) | 2.14287020 |
| 107 | Right ventricular cardiomyopathy (HP:0011663) | 2.13438617 |
| 108 | Hypoglycemic coma (HP:0001325) | 2.12167254 |
| 109 | Nephritis (HP:0000123) | 2.10582111 |
| 110 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09415276 |
| 111 | Abnormality of renin-angiotensin system (HP:0000847) | 2.07669536 |
| 112 | Steatorrhea (HP:0002570) | 2.07137637 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06829199 |
| 114 | Gingivitis (HP:0000230) | 2.06745919 |
| 115 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06524738 |
| 116 | Glomerulopathy (HP:0100820) | 2.05470214 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.05188644 |
| 118 | Autoimmune hemolytic anemia (HP:0001890) | 2.02264816 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 2.02134422 |
| 120 | Hepatosplenomegaly (HP:0001433) | 2.01738534 |
| 121 | Cheilitis (HP:0100825) | 2.01660143 |
| 122 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01265497 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99888321 |
| 124 | Proximal tubulopathy (HP:0000114) | 1.99827960 |
| 125 | Megaloblastic anemia (HP:0001889) | 1.99614338 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.98573548 |
| 127 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98146588 |
| 128 | Generalized aminoaciduria (HP:0002909) | 1.95278409 |
| 129 | Gastrointestinal dysmotility (HP:0002579) | 1.94779842 |
| 130 | Protuberant abdomen (HP:0001538) | 1.94303431 |
| 131 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93428488 |
| 132 | Ketoacidosis (HP:0001993) | 1.93418450 |
| 133 | Hypotension (HP:0002615) | 1.93074557 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92937705 |
| 135 | Obstructive lung disease (HP:0006536) | 1.92937705 |
| 136 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92789256 |
| 137 | Cerebral palsy (HP:0100021) | 1.92569780 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.92386121 |
| 139 | Stomatitis (HP:0010280) | 1.91545424 |
| 140 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90998653 |
| 141 | Abnormality of eosinophils (HP:0001879) | 1.90876156 |
| 142 | Flat acetabular roof (HP:0003180) | 1.90864521 |
| 143 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.90662686 |
| 144 | Dicarboxylic aciduria (HP:0003215) | 1.90662686 |
| 145 | Abnormality of T cells (HP:0002843) | 1.90312428 |
| 146 | Recurrent abscess formation (HP:0002722) | 1.89762125 |
| 147 | Gangrene (HP:0100758) | 1.89041973 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 1.88904312 |
| 149 | Emphysema (HP:0002097) | 1.87668031 |
| 150 | Rectal prolapse (HP:0002035) | 1.87248657 |
| 151 | Colitis (HP:0002583) | 1.87109296 |
| 152 | Bone pain (HP:0002653) | 1.86052627 |
| 153 | Long foot (HP:0001833) | 1.85692974 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.84230282 |
| 155 | Elevated alkaline phosphatase (HP:0003155) | 1.83032671 |
| 156 | Polyneuropathy (HP:0001271) | 1.83032465 |
| 157 | Gastrointestinal inflammation (HP:0004386) | 1.82862519 |
| 158 | Axonal loss (HP:0003447) | 1.82309967 |
| 159 | Recurrent bacterial skin infections (HP:0005406) | 1.80876463 |
| 160 | Spontaneous hematomas (HP:0007420) | 1.80843343 |
| 161 | Subcapsular cataract (HP:0000523) | 1.79156337 |
| 162 | Multiple lipomas (HP:0001012) | 1.78670976 |
| 163 | T lymphocytopenia (HP:0005403) | 1.78654131 |
| 164 | Mesangial abnormality (HP:0001966) | 1.77701316 |
| 165 | Abnormal platelet function (HP:0011869) | 1.77039417 |
| 166 | Impaired platelet aggregation (HP:0003540) | 1.77039417 |
| 167 | Gastrointestinal stroma tumor (HP:0100723) | 1.76906399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.73672668 |
| 2 | TAOK3 | 4.02379882 |
| 3 | ACVR1B | 3.69953396 |
| 4 | TXK | 3.39886964 |
| 5 | TRIB3 | 2.92354886 |
| 6 | ERN1 | 2.76716636 |
| 7 | RIPK4 | 2.54021116 |
| 8 | EPHA2 | 2.39793231 |
| 9 | MAPK15 | 2.28134652 |
| 10 | MST1R | 2.16470980 |
| 11 | PRPF4B | 2.15276021 |
| 12 | SIK1 | 2.12246688 |
| 13 | MAP4K1 | 2.11265720 |
| 14 | GRK6 | 2.11194314 |
| 15 | CAMK1D | 2.07855941 |
| 16 | TESK2 | 2.03193252 |
| 17 | JAK1 | 1.94926456 |
| 18 | EPHB1 | 1.87111147 |
| 19 | RIPK1 | 1.84629168 |
| 20 | LMTK2 | 1.78813215 |
| 21 | FRK | 1.70207829 |
| 22 | PIM1 | 1.59559180 |
| 23 | TBK1 | 1.59556145 |
| 24 | TEC | 1.55937305 |
| 25 | BMX | 1.55889050 |
| 26 | PDK4 | 1.54393796 |
| 27 | PDK3 | 1.54393796 |
| 28 | MAP3K10 | 1.53463928 |
| 29 | CSK | 1.50510624 |
| 30 | ITK | 1.48150832 |
| 31 | MAP3K6 | 1.46500924 |
| 32 | MAP3K1 | 1.45942980 |
| 33 | EPHB2 | 1.39468109 |
| 34 | ICK | 1.39383258 |
| 35 | MAP3K14 | 1.38625582 |
| 36 | STK10 | 1.38556134 |
| 37 | MATK | 1.34314805 |
| 38 | MAP3K11 | 1.33428181 |
| 39 | CDK9 | 1.31978785 |
| 40 | BCKDK | 1.29576929 |
| 41 | MAP2K2 | 1.29208677 |
| 42 | DDR2 | 1.24556429 |
| 43 | SMG1 | 1.23850095 |
| 44 | CDC42BPA | 1.23671107 |
| 45 | PTK6 | 1.20919823 |
| 46 | CDK6 | 1.18106959 |
| 47 | JAK3 | 1.17771819 |
| 48 | PRKG2 | 1.16952791 |
| 49 | MAP2K3 | 1.16252550 |
| 50 | ZAP70 | 1.15795544 |
| 51 | CAMK1G | 1.15449075 |
| 52 | FGFR4 | 1.14750498 |
| 53 | TYK2 | 1.14688779 |
| 54 | BTK | 1.13059058 |
| 55 | IKBKB | 1.03994686 |
| 56 | GSK3A | 1.01650281 |
| 57 | TGFBR2 | 1.01642451 |
| 58 | FGFR3 | 1.01388176 |
| 59 | KSR2 | 1.00121328 |
| 60 | PRKAA2 | 0.97558238 |
| 61 | PDK2 | 0.96626715 |
| 62 | CHUK | 0.93590541 |
| 63 | MAPK11 | 0.92407035 |
| 64 | TESK1 | 0.91932211 |
| 65 | EPHA3 | 0.89956457 |
| 66 | FGR | 0.88585342 |
| 67 | MET | 0.86067754 |
| 68 | PKN2 | 0.81354941 |
| 69 | EEF2K | 0.79719078 |
| 70 | MAP2K6 | 0.79081338 |
| 71 | JAK2 | 0.78376931 |
| 72 | IKBKE | 0.77368485 |
| 73 | PIM2 | 0.74572437 |
| 74 | CDK4 | 0.74341363 |
| 75 | MAP3K3 | 0.73911064 |
| 76 | TNK2 | 0.73813387 |
| 77 | CDK12 | 0.73299134 |
| 78 | STK24 | 0.71600391 |
| 79 | TAOK1 | 0.71596874 |
| 80 | RPS6KA2 | 0.71348039 |
| 81 | MAPK12 | 0.70893867 |
| 82 | MST4 | 0.69845617 |
| 83 | TRPM7 | 0.69511177 |
| 84 | RPS6KB1 | 0.67780122 |
| 85 | RPS6KA1 | 0.64687767 |
| 86 | RPS6KC1 | 0.62108676 |
| 87 | RPS6KL1 | 0.62108676 |
| 88 | TAOK2 | 0.60608286 |
| 89 | HCK | 0.60404249 |
| 90 | NME2 | 0.57705481 |
| 91 | ABL2 | 0.57559630 |
| 92 | PTK2 | 0.56947382 |
| 93 | MAPKAPK2 | 0.56579591 |
| 94 | MAP3K13 | 0.56328549 |
| 95 | BLK | 0.55821131 |
| 96 | ERBB2 | 0.54684985 |
| 97 | MARK2 | 0.53968617 |
| 98 | IRAK4 | 0.53960740 |
| 99 | MAPK4 | 0.53785524 |
| 100 | RET | 0.53405399 |
| 101 | PDK1 | 0.50183231 |
| 102 | LCK | 0.49817619 |
| 103 | DYRK1B | 0.49255037 |
| 104 | PRKAA1 | 0.49124898 |
| 105 | PDGFRB | 0.49070767 |
| 106 | PIK3CA | 0.48979024 |
| 107 | PDPK1 | 0.47686959 |
| 108 | MAP3K2 | 0.47314357 |
| 109 | NLK | 0.46847866 |
| 110 | MAPKAPK3 | 0.46804556 |
| 111 | CSF1R | 0.46072259 |
| 112 | TYRO3 | 0.45210918 |
| 113 | HIPK2 | 0.44984701 |
| 114 | PRKACG | 0.43428289 |
| 115 | PRKCZ | 0.43250506 |
| 116 | PAK4 | 0.43018486 |
| 117 | LYN | 0.42782862 |
| 118 | FES | 0.42777274 |
| 119 | PDGFRA | 0.41382417 |
| 120 | MAP3K7 | 0.41246254 |
| 121 | MARK3 | 0.40762798 |
| 122 | IRAK2 | 0.40153400 |
| 123 | NEK9 | 0.40117948 |
| 124 | SIK2 | 0.38498039 |
| 125 | SYK | 0.37983951 |
| 126 | MAPK7 | 0.37711541 |
| 127 | TLK1 | 0.37370358 |
| 128 | MTOR | 0.37103311 |
| 129 | AKT3 | 0.36998288 |
| 130 | RPS6KA4 | 0.36947038 |
| 131 | FYN | 0.36862716 |
| 132 | BRAF | 0.36581729 |
| 133 | RPS6KA6 | 0.36496219 |
| 134 | KIT | 0.36298175 |
| 135 | TSSK6 | 0.34177741 |
| 136 | IGF1R | 0.34113637 |
| 137 | NME1 | 0.33816905 |
| 138 | PRKD2 | 0.33344234 |
| 139 | LRRK2 | 0.30291359 |
| 140 | INSR | 0.29908362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.73623125 |
| 2 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 3.81206598 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.65499124 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.29615076 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.93292096 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.82921745 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.72172375 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.32588030 |
| 9 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.28882487 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14559346 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11632671 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.11358989 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09684994 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.97746141 |
| 15 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.90196073 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86702747 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.84727168 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77985866 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.74542628 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.62672610 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.62498992 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.57255752 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53556907 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47369023 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41323084 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40420188 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35872923 |
| 28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30988612 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.30036079 |
| 30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.29508365 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26937751 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23983265 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22371454 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.22006465 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19767037 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19524701 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.17014780 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15085660 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14846910 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14174838 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13473294 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13107047 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12031988 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11568088 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08557723 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08143603 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07663727 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 1.04941407 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01528845 |
| 50 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.00844438 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99383048 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98007365 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.97834652 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.97710287 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97431630 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97277990 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95326171 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92327112 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90489751 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90430690 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89965575 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87779344 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87376080 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84315034 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84283886 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82663890 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82328013 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.79599634 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78519323 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75538146 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.73178296 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.73117003 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69476760 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69241438 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69130869 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68992981 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67645207 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66468675 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65072629 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64604653 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63261440 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.63022906 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62128222 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.61768229 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.59530548 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59492081 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58328295 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57968242 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57661981 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.55605552 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52510059 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52380033 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51877685 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51385972 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51276884 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50247794 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47548029 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47354563 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47144599 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47114650 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.46875994 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45778332 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45569156 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44489200 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43050175 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42975126 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42822571 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42120339 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41796667 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41612067 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41573759 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40212514 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.38125073 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38054820 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36922242 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.36609999 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36532670 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35973087 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35355045 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.35134476 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32728140 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32154226 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31316569 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31054178 |
| 125 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30230622 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29242864 |
| 127 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29073906 |
| 128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28819507 |
| 129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28384599 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27822868 |
| 131 | Lysosome_Homo sapiens_hsa04142 | 0.27076799 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.26972614 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25585103 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.25082306 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22598292 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | 0.21806688 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21439844 |

